Aesica has received continuing FDA Approvals for its bulk manufacturing and packaging operations in Germany. The Zwickau site, which manufactures pharmaceutical tablets, capsules and controlled release products, and the Monheim site, which houses logistics and distribution centers, successfully completed pre-approval inspections. In addition, both sites had successful inspections from ANVISA for the Brazil market, as well as from the German Health Agency. Dr. Werner Schick, Aesica’s general man...